Aires Pharmaceuticals (San Diego, CA) a clinical-stage pharmaceutical company focused on small molecule combination therapy for the treatment of pulmonary arterial hypertension, closed a $20M Series B financing. Participants include MPM Capital and ProQuest Investments.